747
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Effect of terlipressin on systemic and hepatic hemodynamics in patients undergoing liver transplantation

, , , &
Pages 432-439 | Received 17 Mar 2023, Accepted 08 May 2023, Published online: 22 May 2023

References

  • Schroeder RA, Collins BH, Tuttle-Newhall E, et al. Intraoperative fluid management during orthotopic liver transplantation. J Cardiothorac Vasc Anesth. 2004 Aug 1;18(4):438–441.
  • Skagen CL, Said A. Vasoconstrictor use in liver transplantation: is there evidence for rational use? Minerva Gastroenterol Dietol. 2010 Sep 1;56(3):279–296.
  • Ginés P, Berl T, Bernardi M, et al. Hyponatremia in cirrhosis: from pathogenesis to treatment. Hepatology. 1998 Sep 1;28(3):851–864.
  • Hong SH, Lee JM, Choi JH, et al. Perioperative assessment of terlipressin infusion during living donor liver transplantation. J Int Med Res. 2012 Feb;40(1):225–236.
  • Fayed N, Refaat EK, Yassein TE, et al. Effect of perioperative terlipressin infusion on systemic, hepatic, and renal hemodynamics during living donor liver transplantation. J Crit Care. 2013 Oct 1;28(5):775–782.
  • Mukhtar A, Salah M, Aboulfetouh F, et al. The use of terlipressin during living donor liver transplantation: effects on systemic and splanchnic hemodynamics and renal function. Crit Care Med. 2011 Jun 1;39(6):1329–1334.
  • Kalambokis GN, Pappas K, Tsianos EV. Differential effects of terlipressin on pulmonary and systemic hemodynamics in patients with cirrhosis and pulmonary hypertension: an echo study. Angiology. 2012 Apr;63(3):199–205.
  • Gavriilidis P, Hidalgo E, Sutcliffe RP, et al. Terlipressin versus placebo in living donor liver transplantation. Hepatobiliary & pancreatic diseases international: HBPD INT. 2021 Feb 13; 21(1): 76–79.
  • Møller S, Hansen EF, Becker U, et al. Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients. Liver. 2000 Feb;20(1):51–59.
  • Kalambokis G, Economou M, Paraskevi K, et al. Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis. J Gastroenterol Hepatol. 2005 Jul;20(7):1075–1081.
  • Narahara Y, Kanazawa H, Taki Y, et al. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis. J Gastroenterol Hepatol. 2009 Nov;24(11):1791–1797.
  • Ibrahim N, Hasanin A, AbdAllah S, et al. The haemodynamic effects of the perioperative terlipressin infusion in living donor liver transplantation: a randomised controlled study. Indian J Anaesth. 2015 Mar;59(3):156.
  • Mahdy MM, Abbas MS, Kamel EZ, et al. Effects of terlipressin infusion during hepatobiliary surgery on systemic and splanchnic haemodynamics, renal function and blood loss: a double-blind, randomized clinical trial. BMC Anesthesiol. 2019 Dec;19(1):1–9.
  • Granger DN, Richardson PD, Kvietys PR, et al. Intestinal blood flow. Gastroenterology. 1980 Apr 1;78(4):837–863.
  • Won YJ, Kim HJ, Lim BG, et al. Effect of perioperative terlipressin on postoperative renal function in patients who have undergone living donor liver transplantation: a meta-analysis of randomized controlled trials. Transplant Proc. 2015;47(6):1917–1925. Elsevier. DOI:10.1016/j.transproceed.2015.06.023.
  • Reddy MS, Kaliamoorthy I, Rajakumar A, et al. Double‐blind randomized controlled trial of the routine perioperative use of terlipressin in adult living donor liver transplantation. Liver Transpl. 2017 Aug;23(8):1007–1014.
  • Mukhtar A, Aboulfetouh F, Obayah G, et al. The safety of modern hydroxyethyl starch in living donor liver transplantation: a comparison with human albumin. Anesthesia & Analgesia. 2009 Sep 1;109(3):924–930.
  • Wagener G, Gubitosa G, Renz J, et al. Vasopressin decreases portal vein pressure and flow in the native liver during liver transplantation. Liver Transpl. 2008 Nov;14(11):1664–1670.